Approaches to Aggregation and Decision Making—A Health Economics Approach: An ISPOR Special Task Force Report [5]

Value in Health

Volumn 21, Issue 2, 2018, Pages 146-154

  Phelps, Charles E ^a   Lakdawalla, Darius N ^b   Basu, Anirban ^c   Drummond, Michael F ^d   Towse, Adrian ^e   Danzon, Patricia M ^f  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF YORK   (United Kingdom)

^e Office of Health Economics   (United Kingdom)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

aggregation; cost effectiveness; equity; multi dimensioned benefits

Indexed keywords

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BUDGET; CLINICAL DECISION MAKING; COST EFFECTIVENESS ANALYSIS; HEALTH CARE; HUMAN; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REIMBURSEMENT; RESOURCE ALLOCATION; ADVISORY COMMITTEE; COST BENEFIT ANALYSIS; DECISION MAKING; ECONOMICS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE POLICY; OUTCOME ASSESSMENT; PROCEDURES; UNITED STATES;

ADVISORY COMMITTEES; BUDGETS; COST-BENEFIT ANALYSIS; DECISION MAKING; DELIVERY OF HEALTH CARE; HEALTH EXPENDITURES; HEALTH POLICY; HEALTH PRIORITIES; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY-ADJUSTED LIFE YEARS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES;

EID: 85042310786     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2017.12.010     Document Type: Article

References (40)

1. Bator, F.M., The simple analytics of welfare maximization. Am Econ Rev 47 (1957), 22–59.
2. Garrison, L.P., Pauly, M.V., Willke, R.J., Neumann, P.J., An overview of value, perspective, and decision context—a health economics approach: an ISPOR Special Task Force report [2]. Value Health 21 (2018), 124–130.
3. Danzon, P.M., Drummond, M.F., Towse, A., Pauly, M.V., Objectives, budgets, thresholds, and opportunity costs—a health economics approach: an ISPOR Special Task Force report [4]. Value Health 21 (2018), 140–145.
4. Lakdawalla, D.N., Doshi, J.A., Garrison, L.P., Phelps, C.E., Basu, A., Danzon, P.M., Defining elements of value in health care—a health economics approach: an ISPOR Special Task Force report [3]. Value Health 21 (2018), 131–139.
5. Verguet, S., Kim, J.J., Jamison, D.T., Extended cost-effectiveness analysis for health policy assessment: a tutorial. Pharmacoeconomics 34 (2016), 913–923.
6. Arrow, K.J., Aspects of the Theory of Risk Bearing in the Theory of Risk Aversion. Helsinki, Finland: Yrjo Jahnssonin Saatio, 1965. Reprinted Essays in the Theory of Risk Bearing, 1971, Markham Publishing Co., Chicago, IL, 90–109.
7. Pratt, J.W., Risk aversion in the large and in the small. Econometrica 32 (1964), 122–136.
8. Garber, A.M., Phelps, C.E., Economic foundations of cost-effectiveness analysis. J Health Econ 16 (1997), 1–31.
9. Chetty, R., A new method of estimating risk aversion. Am Econ Rev 96 (2006), 1821–1834.
10. Keeney, R.L., Raiffa, H., Decisions with Multiple Objectives: Preferences and Value Tradeoffs. 1976, Wiley, New York, NY.
11. Saaty, T.L., The Analytical Hierarchy Process, Planning, Priority. Resource Allocation, 1980, RWS Publications.
12. von Winterfeldt, D., Edwards, W., Decision Analysis and Behavioural Research. 1986, Cambridge University Press, New York, NY.
13. Edwards, W., Barron, F.H., SMARTS and SMARTER: improved simple methods for multiattribute utility measurement. Organ Behav Hum Decis Process 60 (1994), 206–325.
14. Phelps, C.E., Madhavan, G., Using multi-criteria approaches to assess the value of health care. Value Health 20 (2017), 251–255.
15. Barron, F.H., Barrett, B.E., Decision quality using ranked attribute weights. Manage Sci 42 (1996), 1515–1523.
16. Phelps CE, Madhavan G. Resource allocation in decision support frameworks. Cost Eff Resourc Alloc. 16(S1), in press, 2018.
17. Tan-Torres Edejer, T., Baltussen, R.M., Adam, T., et al. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. 2003, World Health Organization, Geneva, Switzerland.
18. Neumann, P.J., Sanders, G.D., Russell, L.B., et al. Cost-Effectiveness in Health and Medicine. 2016, Oxford University Press, New York, NY.
19. Phillips, L.D., Bana e Costa, C.A., Transparent prioritisation, budgeting and resource allocation with multi-criteria decision analysis and decision conferencing. Ann Oper Res 154 (2007), 51–68.
20. Marsh, K., IJzerman, M., Thokala, P., et al. Multiple criteria decision analysis for health care decision making—emerging good practices: report 2 of the ISPOR MCDA Emerging Good Practices Task Force. Value Health 19 (2016), 125–137.
21. Galton, F., Vox populi. Nature 75 (1907), 450–451.
22. Balinski, M., Laraki, R., Majority Judgment: Measuring, Ranking, and Electing. 2010, MIT Press, Cambridge, MA.
23. Hajer, M.A., Wagenaar, H., (eds.) Deliberative Policy Analysis: Understanding Governance in the Network Society, 2003, Cambridge University Press, Cambridge, UK.
24. Culyer, A.J., Lomas, J., Deliberative processes and evidence-informed decision making in health care: Do they work and how might we know?. Evid Policy 2 (2006), 357–371.
25. National Institute for Health and Care Excellence. A guide to the methods of technology appraisal, 2003 Available from: http://www.nice.org.uk/aboutnice/howwework/devnicetech/guidetothemethodsoftechnologyappraisal.jsp. [Accessed December 5, 2013].
26. Rawlins, M.D., Culyer, A.J., National Institute for Clinical Excellence and its value judgments. BMJ 329 (2004), 224–227.
27. Rawlins, M., Barnett, D., Stevens, A., Pharmacoeconomics: NICE's approach to decision making. Br J Clin Pharmacol 70 (2010), 346–349.
28. George, B., Harris, A., Mitchell, A., Cost-effectiveness analysis and the consistency of decision-making: evidence from pharmaceutical reimbursement in Australia (1991–1996). Pharmacoeconomics 19 (2001), 1103–1109.
29. Smith, J.C., The structure, role and procedures of the US Advisory Committee on Immunization Practices (ACIP). Vaccine 285 (2010), A68–A75.
30. Agency for Healthcare Research and Quality. US Preventive Services Task Force Procedure Manual. AHRQ Publication No. 08-05118-EF. Rockville, MD: Agency for Healthcare Research and Quality. July, 2008. Available from: https://www.uspreventiveservicestaskforce.org/Home/GetFile/6/7/procmanual/pdf. [Accessed January 4, 2018].
31. Daniels, N., Sabin, J.E., Accountability for reasonable priority setting. BMJ, 9, 2008, a1850.
32. Arrow, K.J., A difficulty in the concept of social welfare. J Polit Econ 58 (1950), 328–346.
33. Gibbard, A., Manipulation of voting schemes: a general result. Econometrica 41 (1973), 587–601.
34. Satterthwaite, M.A., Strategy-proofness and Arrow's conditions: existence and correspondence theorems for voting procedures and social welfare functions. J Econ Theory 10 (1975), 187–217.
35. Plott, C.R., Levine, M.E., A model of agenda influence on committee decisions. Am Econ Rev 68 (1978), 146–160.
36. Kahneman, D., Thinking, Fast and Slow. 2011, Farrar, Straus and Giroux, New York.
37. Basu, A., Sullivan, S.D., Towards a hedonic value framework in health care. Value Health 20 (2017), 261–265.
38. Lakdawalla, D., Malani, A., Reif, J., The insurance value of medical innovation. J Public Econ 145 (2017), 94–102.
39. Nussbaum, M., Capabilities as fundamental entitlements. Fem Econ 9 (2003), 33–59.
40. Anand, P., Hunter, G., Carter, I., et al. The development of capability indicators. J Human Dev Capabil 10 (2009), 125–152.